CN1274584A - 光合细菌作为医药保健品的应用及其制作方法及其产品 - Google Patents
光合细菌作为医药保健品的应用及其制作方法及其产品 Download PDFInfo
- Publication number
- CN1274584A CN1274584A CN99107591A CN99107591A CN1274584A CN 1274584 A CN1274584 A CN 1274584A CN 99107591 A CN99107591 A CN 99107591A CN 99107591 A CN99107591 A CN 99107591A CN 1274584 A CN1274584 A CN 1274584A
- Authority
- CN
- China
- Prior art keywords
- rhodospirillum
- sulfur
- red non
- red
- medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 35
- 230000036541 health Effects 0.000 title claims abstract description 17
- 230000000243 photosynthetic effect Effects 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title description 5
- 241000190967 Rhodospirillum Species 0.000 claims abstract description 68
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 9
- 230000036039 immunity Effects 0.000 claims abstract description 9
- 201000011510 cancer Diseases 0.000 claims abstract description 7
- 239000000701 coagulant Substances 0.000 claims abstract description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 68
- 239000011593 sulfur Substances 0.000 claims description 68
- 229910052717 sulfur Inorganic materials 0.000 claims description 68
- 238000000034 method Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 238000009472 formulation Methods 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 239000012531 culture fluid Substances 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 208000008469 Peptic Ulcer Diseases 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- 241000131970 Rhodospirillaceae Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229960005305 adenosine Drugs 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 235000013877 carbamide Nutrition 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000191368 Chlorobi Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241001425707 Chlorobiaceae Species 0.000 description 1
- 241000190834 Chromatiaceae Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 101001130226 Homo sapiens Phosphatidylcholine-sterol acyltransferase Proteins 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102100031538 Phosphatidylcholine-sterol acyltransferase Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- -1 hydroxyl radical free radical Chemical class 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical class [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000029983 protein stabilization Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99107591A CN1274584A (zh) | 1999-05-21 | 1999-05-21 | 光合细菌作为医药保健品的应用及其制作方法及其产品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99107591A CN1274584A (zh) | 1999-05-21 | 1999-05-21 | 光合细菌作为医药保健品的应用及其制作方法及其产品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1274584A true CN1274584A (zh) | 2000-11-29 |
Family
ID=5272834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99107591A Pending CN1274584A (zh) | 1999-05-21 | 1999-05-21 | 光合细菌作为医药保健品的应用及其制作方法及其产品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1274584A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827301A1 (fr) * | 2001-07-13 | 2003-01-17 | Blue Energy Laboratoire | Procedes de fixation/complementation de molecules biologiquement actives par des cyanobacteries et des micro-algues ou des fractions de cyanobacteries et de micro-algues |
| NL1022153C2 (nl) * | 2002-12-12 | 2004-06-15 | Tno | Cholesterol verlagend preparaat, voedingssupplement en voedingsmiddel en werkwijzen voor de bereiding daarvan. |
| WO2018229223A1 (en) | 2017-06-15 | 2018-12-20 | Ezcol B.V. | Ldl-cholesterol-lowering cell extract and food supplement |
| WO2023009000A1 (en) | 2021-07-29 | 2023-02-02 | Semilla Health B.V. | Poultry feed for lowering cholesterol level in egg yolks |
-
1999
- 1999-05-21 CN CN99107591A patent/CN1274584A/zh active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827301A1 (fr) * | 2001-07-13 | 2003-01-17 | Blue Energy Laboratoire | Procedes de fixation/complementation de molecules biologiquement actives par des cyanobacteries et des micro-algues ou des fractions de cyanobacteries et de micro-algues |
| NL1022153C2 (nl) * | 2002-12-12 | 2004-06-15 | Tno | Cholesterol verlagend preparaat, voedingssupplement en voedingsmiddel en werkwijzen voor de bereiding daarvan. |
| WO2004052380A1 (en) * | 2002-12-12 | 2004-06-24 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same |
| JP2006513176A (ja) * | 2002-12-12 | 2006-04-20 | ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー | コレステロールを低下させる調製物、食品サプリメントおよび食品、ならびにそれらの製造法 |
| US7749513B2 (en) | 2002-12-12 | 2010-07-06 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Methods of using a cholesterol-lowering preparation, food supplement and foodstuff |
| JP4814524B2 (ja) * | 2002-12-12 | 2011-11-16 | ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー | コレステロールを低下させる調製物 |
| EP3189845A1 (en) * | 2002-12-12 | 2017-07-12 | ezCol B.V. | Cholesterol-lowering preparation, food supplement and foodstuff, and methods preparing same |
| WO2018229223A1 (en) | 2017-06-15 | 2018-12-20 | Ezcol B.V. | Ldl-cholesterol-lowering cell extract and food supplement |
| JP2020524500A (ja) * | 2017-06-15 | 2020-08-20 | エズコル ビー.ヴイ. | Ldl−コレステロールを低下させる細胞抽出物および食品サプリメント |
| US11026981B2 (en) | 2017-06-15 | 2021-06-08 | Ezcol B.V. | LDL-cholesterol-lowering cell extract and food supplement |
| WO2023009000A1 (en) | 2021-07-29 | 2023-02-02 | Semilla Health B.V. | Poultry feed for lowering cholesterol level in egg yolks |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1283171C (zh) | 富硒益生菌饲料添加剂的生产方法及其产品 | |
| CN103766650A (zh) | 一种蛋鸡饲料添加剂及其制备 | |
| KR101834227B1 (ko) | 반추동물의 반추위 내 메탄가스의 생성을 억제하기 위한 사료 조성물 | |
| CN1643130A (zh) | 硒酵母产物,制备硒酵母产物的方法以及所述产物在制备食品、膳食补充品或药品中的用途 | |
| KR20110055697A (ko) | 셀레노히드록시산 화합물을 사용하여 셀레늄이 강화된 광합성 미생물, 영양물, 화장품 또는 약물에서의 그의 용도 | |
| CN111714572A (zh) | 一种基于植物乳杆菌的益生菌片剂及其制备方法 | |
| CN103827288A (zh) | 藻类的培养方法与含有藻酸的组合物的制备方法 | |
| CN101492644B (zh) | 一种生物合成15n标记螺旋藻的方法 | |
| CN103865816A (zh) | 一种富硒、锗酵母粉 | |
| CN113100345A (zh) | 一种提高免疫力猪饲料添加剂及猪饲料的制备方法 | |
| CN105624071A (zh) | 一株唾液乳杆菌xjp2及其应用 | |
| CN1895066A (zh) | 抗体酸奶片(粉) | |
| CN1965673A (zh) | 一种微生态制剂 | |
| WO2019192182A1 (zh) | 裂壶藻及其制剂在提高动物产品品质及产量中的应用 | |
| CN101032527A (zh) | 酪酸菌活菌制剂及其制备方法 | |
| CN1252835A (zh) | 添加了来源于酵母的硒盐的食品以及来源于酵母的硒盐的制备方法 | |
| CN1186985C (zh) | 肽奶粉及其制备工艺 | |
| CN1142265C (zh) | 一种耐高硒菌种及其制法和它在制备防治砷中毒的药中的应用 | |
| CN1207055C (zh) | 冬虫夏草生物活性多维强化剂的制备方法 | |
| CN1034860A (zh) | 小球藻提取物及其应用 | |
| CN1135933C (zh) | 一种多功能营养液及其制造方法 | |
| CN1127917C (zh) | 一种延缓衰老的功能性营养保健品 | |
| CN1203878C (zh) | 有机态微量元素补充剂 | |
| KR102699079B1 (ko) | 비타민 a, d3, e를 함유한 나노제품 및 이를 이용한 동물용 영양제 | |
| CN1442151A (zh) | 麦可芙莱免疫液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent for invention or patent application | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ZHONGWEI HUAMEI PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD BEIJING TO: HONGDIKANGHUA BIO-ENGINEERING TECHNOLOGY CO LTD, BEIJING |
|
| CP03 | Change of name, title or address |
Address after: 100086 Beijing city Haidian District zhichunli sigma apartment block B room 1705 Applicant after: Hongdikanghua Bio-Engineering Technology Co Ltd, Beijing Address before: The 100054 Beijing Fengtai District right outside the West No. ten Applicant before: Zhongwei Huamei Medicine Technology Development Co., Ltd., Beijing |
|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: JIAHUA BIOLOGICAL TECHNOLOGY ( SHANDONG ) CO., LT Free format text: FORMER OWNER: HONGDIKANGHUA BIO-ENGINEERING TECHNOLOGY CO LTD, BEIJING Effective date: 20030327 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20030327 Address after: 273500 No. 1518 West Ring Road, Jining, Shandong, Zoucheng Applicant after: Jiahua Biotechnology (Shandong) Co., Ltd. Address before: 100086 Beijing city Haidian District zhichunli sigma apartment block B room 1705 Applicant before: Hongdikanghua Bio-Engineering Technology Co Ltd, Beijing |
|
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |